| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |